Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated with Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population
Overview
Affiliations
Objective: Genome-wide association studies have identified common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, HHEX/IDE, EXT2, and LOC387761 loci that significantly increase the risk of type 2 diabetes. We aimed to replicate these observations in a population-based cohort of Chinese Hans and examine the associations of these variants with type 2 diabetes and diabetes-related phenotypes.
Research Design And Methods: We genotyped 17 single nucleotide polymorhisms (SNPs) in 3,210 unrelated Chinese Hans, including 424 participants with type 2 diabetes, 878 with impaired fasting glucose (IFG), and 1,908 with normal fasting glucose.
Results: We confirmed the associations between type 2 diabetes and variants near CDKAL1 (odds ratio 1.49 [95% CI 1.27-1.75]; P = 8.91 x 10(-7)) and CDKN2A/B (1.31 [1.12-1.54]; P = 1.0 x 10(-3)). We observed significant association of SNPs in IGF2BP2 (1.17 [1.03-1.32]; P = 0.014) and SLC30A8 (1.12 [1.01-1.25]; P = 0.033) with combined IFG/type 2 diabetes. The SNPs in CDKAL1, IGF2BP2, and SLC30A8 were also associated with impaired beta-cell function estimated by homeostasis model assessment of beta-cell function. When combined, each additional risk allele from CDKAL1-rs9465871, CDKN2A/B-rs10811661, IGF2BP2-rs4402960, and SLC30A8-rs13266634 increased the risk for type 2 diabetes by 1.24-fold (P = 2.85 x 10(-7)) or for combined IFG/type 2 diabetes by 1.21-fold (P = 6.31 x 10(-11)). None of the SNPs in EXT2 or LOC387761 exhibited significant association with type 2 diabetes or IFG. Significant association was observed between the HHEX/IDE SNPs and type 2 diabetes in individuals from Shanghai only (P < 0.013) but not in those from Beijing (P > 0.33).
Conclusions: Our results indicate that in Chinese Hans, common variants in CDKAL1, CDKN2A/B, IGF2BP2, and SLC30A8 loci independently or additively contribute to type 2 diabetes risk, likely mediated through beta-cell dysfunction.
Zinc homeostasis and redox alterations in obesity.
Franco C, Canzoniero L Front Endocrinol (Lausanne). 2024; 14:1273177.
PMID: 38260166 PMC: 10800374. DOI: 10.3389/fendo.2023.1273177.
Bartel I, Koszarska M, Strzalkowska N, Tzvetkov N, Wang D, Horbanczuk J Int J Mol Sci. 2023; 24(11).
PMID: 37298715 PMC: 10253535. DOI: 10.3390/ijms24119765.
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.
Fang X, Miao R, Wei J, Wu H, Tian J Comput Struct Biotechnol J. 2022; 20:5935-5951.
PMID: 36382190 PMC: 9646750. DOI: 10.1016/j.csbj.2022.10.030.
Huang X, Han Y, Jang K, Kim M Antioxidants (Basel). 2022; 11(6).
PMID: 35740093 PMC: 9231325. DOI: 10.3390/antiox11061196.
Amin U, Parvez N, Rahman T, Rakibul Hasan M, Das K, Jahan S Diabetol Metab Syndr. 2022; 14(1):18.
PMID: 35090536 PMC: 8796445. DOI: 10.1186/s13098-021-00782-w.